Quirine E M Stassen, Frank M Riemers, Hannah Reijmerink, Peter A J Leegwater, Louis C Penning
BACKGROUND: In the last decade canine models have been used extensively to study genetic causes of neurological disorders such as epilepsy and Alzheimer's disease and unravel their pathophysiological pathways. Reverse transcription quantitative polymerase chain reaction is a sensitive and inexpensive method to study expression levels of genes involved in disease processes. Accurate normalisation with stably expressed so-called reference genes is crucial for reliable expression analysis.
RESULTS: Following the minimum information for publication of quantitative real-time PCR experiments precise guidelines, the expression of ten frequently used reference genes, namely YWHAZ, HMBS, B2M, SDHA, GAPDH, HPRT, RPL13A, RPS5, RPS19 and GUSB was evaluated in seven brain regions (frontal lobe, parietal lobe, occipital lobe, temporal lobe, thalamus, hippocampus and cerebellum) and whole brain of healthy dogs. The stability of expression varied between different brain areas. Using the GeNorm and Normfinder software HMBS, GAPDH and HPRT were the most reliable reference genes for whole brain. Furthermore based on GeNorm calculations it was concluded that as little as two to three reference genes are sufficient to obtain reliable normalisation, irrespective the brain area.
CONCLUSIONS: Our results amend/extend the limited previously published data on canine brain reference genes. Despite the excellent expression stability of HMBS, GAPDH and HRPT, the evaluation of expression stability of reference genes must be a standard and integral part of experimental design and subsequent data analysis.
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
[PMID:
12184808]
Biotechniques. 2004 Jul;37(1):112-4, 116, 118-9
[PMID:
15283208]
Cancer Res. 2004 Aug 1;64(15):5245-50
[PMID:
15289330]
Cell. 1999 Aug 6;98(3):365-76
[PMID:
10458611]
Science. 2005 Jan 7;307(5706):81
[PMID:
15637270]
Genes Immun. 2005 Jun;6(4):279-84
[PMID:
15815687]
Anal Biochem. 2005 Sep 1;344(1):141-3
[PMID:
16054107]
J Mol Med (Berl). 2005 Dec;83(12):1014-24
[PMID:
16211407]
Nature. 2005 Dec 8;438(7069):803-19
[PMID:
16341006]
Brain Res. 2007 Feb 9;1132(1):20-8
[PMID:
17188656]
Vet Immunol Immunopathol. 2007 May 15;117(1-2):55-66
[PMID:
17346803]
Mamm Genome. 2007 Jul;18(6-7):444-51
[PMID:
17653794]
Synapse. 2008 Apr;62(4):302-9
[PMID:
18241047]
BMC Mol Biol. 2008;9:62
[PMID:
18611280]
J Mol Neurosci. 2009 Mar;37(3):238-53
[PMID:
18607772]
Clin Chem. 2009 Apr;55(4):611-22
[PMID:
19246619]
Dis Model Mech. 2010 Jan-Feb;3(1-2):27-34
[PMID:
20075379]
BMC Mol Biol. 2010;11:74
[PMID:
20858237]
Nat Rev Genet. 2008 Sep;9(9):713-25
[PMID:
18714291]
PLoS One. 2011;6(5):e17107
[PMID:
21655323]
Vet J. 2011 Aug;189(2):155-9
[PMID:
21752675]
PLoS Genet. 2011 Jul;7(7):e1002194
[PMID:
21829378]
Int J Mol Sci. 2011;12(9):5461-70
[PMID:
22016602]
Mamm Genome. 2012 Feb;23(1-2):28-39
[PMID:
22037590]
Vet J. 2012 Mar;191(3):279-81
[PMID:
22005167]
Curr Alzheimer Res. 2012 Mar;9(3):298-314
[PMID:
21875411]
Int J Legal Med. 2012 Nov;126(6):943-52
[PMID:
23010907]
Theory Biosci. 2012 Dec;131(4):215-23
[PMID:
22588998]
Epilepsia. 2013 Apr;54(4):571-9
[PMID:
23506100]
Mol Biotechnol. 2013 May;54(1):47-57
[PMID:
22531949]
Biochim Biophys Acta. 2013 Sep;1832(9):1384-9
[PMID:
23528711]
Nat Methods. 2013 Nov;10(11):1063-7
[PMID:
24173381]
Mol Neurobiol. 2014 Apr;49(2):893-9
[PMID:
24135907]
Anal Biochem. 2006 Sep 1;356(1):36-43
[PMID:
16844072]
